MEDICUS PHARMA LTD (MDCX:NASDAQ)
$1.88 -0.27 (-12.5581%)
Analysed MEDICUS PHARMA LTD (MDCX:NASDAQ) News Sources
Medicus Pharma to focus SkinJect development exclusively on Gorlin syndrome patients
21-09-2026
proactiveinvestors.com
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
29-09-2026
yahoo.com
Medicus Pharma files streamlined Phase 2b/3 prostate cancer trial design with FDA
29-09-2026
proactiveinvestors.com
Medicus Pharma seeks FDA alignment on streamlined Phase 2b/3 Teverelix study
05-10-2026
yahoo.com
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
08-10-2026
yahoo.com
Medicus Pharma targets partnerships and clinical milestones as oncology pipeline advances
08-10-2026
proactiveinvestors.com
Medicus Pharma Outlines Clinical Development Strategy Across Three Drug Programs Following $90 Million in Financing
08-10-2026
advfn.com
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
26-10-2026
yahoo.com
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
27-10-2026
yahoo.com
Medicus Pharma CEO to present precision oncology progress at global biotech conferences
27-10-2026
proactiveinvestors.com
What is the current price of MEDICUS PHARMA LTD (MDCX:NASDAQ)?
The current price of MEDICUS PHARMA LTD (MDCX:NASDAQ) is $1.88.
MEDICUS PHARMA LTD (MDCX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MEDICUS PHARMA LTD (MDCX:NASDAQ) since the previous trading day is $-0.27.
MEDICUS PHARMA LTD (MDCX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MEDICUS PHARMA LTD (MDCX:NASDAQ) since the previous trading day is -12.5581%.
What is the most recent average sentiment score for MEDICUS PHARMA LTD (MDCX:NASDAQ)?
The most recent average sentiment score for MEDICUS PHARMA LTD (MDCX:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for MEDICUS PHARMA LTD (MDCX:NASDAQ)?
The most recent sentiment for MEDICUS PHARMA LTD (MDCX:NASDAQ) is .
SEC-8K** Filing Available For MEDICUS PHARMA LTD (MDCX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.